160 related articles for article (PubMed ID: 26647881)
1. Identification of key genes in hepatocellular carcinoma and validation of the candidate gene, cdc25a, using gene set enrichment analysis, meta-analysis and cross-species comparison.
Lu X; Sun W; Tang Y; Zhu L; Li Y; Ou C; Yang C; Su J; Luo C; Hu Y; Cao J
Mol Med Rep; 2016 Feb; 13(2):1172-8. PubMed ID: 26647881
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of CDC25A phosphatase is associated with hypergrowth activity and poor prognosis of human hepatocellular carcinomas.
Xu X; Yamamoto H; Sakon M; Yasui M; Ngan CY; Fukunaga H; Morita T; Ogawa M; Nagano H; Nakamori S; Sekimoto M; Matsuura N; Monden M
Clin Cancer Res; 2003 May; 9(5):1764-72. PubMed ID: 12738732
[TBL] [Abstract][Full Text] [Related]
3. Aberrant Polo-like kinase 1-Cdc25A pathway in metastatic hepatocellular carcinoma.
Wang XQ; Zhu YQ; Lui KS; Cai Q; Lu P; Poon RT
Clin Cancer Res; 2008 Nov; 14(21):6813-20. PubMed ID: 18980975
[TBL] [Abstract][Full Text] [Related]
4. Rock2 regulates Cdc25A through ubiquitin proteasome system in hepatocellular carcinoma cells.
Liu T; Yu X; Li G; Yuan R; Wang Q; Tang P; Wu L; Liu X; Peng X; Shao J
Exp Cell Res; 2012 Oct; 318(16):1994-2003. PubMed ID: 22705122
[TBL] [Abstract][Full Text] [Related]
5. MiR-675 Promotes the Growth of Hepatocellular Carcinoma Cells Through the Cdc25A Pathway.
Yu YQ; Weng J; Li SQ; Li B; Lv J
Asian Pac J Cancer Prev; 2016; 17(8):3881-5. PubMed ID: 27644634
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA let-7c Inhibits Cell Proliferation and Induces Cell Cycle Arrest by Targeting CDC25A in Human Hepatocellular Carcinoma.
Zhu X; Wu L; Yao J; Jiang H; Wang Q; Yang Z; Wu F
PLoS One; 2015; 10(4):e0124266. PubMed ID: 25909324
[TBL] [Abstract][Full Text] [Related]
7. [A cDNA microarray study of the differential expression of genes in signal transduction pathway during hepatocarcinogenesis in tree shrews].
Chen YN; Cao J; Su JJ; Li Y
Zhonghua Gan Zang Bing Za Zhi; 2005 Oct; 13(10):763-7. PubMed ID: 16248950
[TBL] [Abstract][Full Text] [Related]
8. Identification of intragenic methylation in the TUSC1 gene as a novel prognostic marker of hepatocellular carcinoma.
Shimizu D; Kanda M; Nomoto S; Oya H; Takami H; Hibino S; Suenaga M; Inokawa Y; Hishida M; Takano N; Nishikawa Y; Yamada S; Fujii T; Nakayama G; Sugimoto H; Koike M; Fujiwara M; Kodera Y
Oncol Rep; 2014 Mar; 31(3):1305-13. PubMed ID: 24366000
[TBL] [Abstract][Full Text] [Related]
9. Cross-species hybridization of woodchuck hepatitis viral infection-induced woodchuck hepatocellular carcinoma using human, rat and mouse oligonucleotide microarrays.
Wang F; Kuang Y; Salem N; Anderson PW; Lee Z
J Gastroenterol Hepatol; 2009 Apr; 24(4):605-17. PubMed ID: 19175833
[TBL] [Abstract][Full Text] [Related]
10. CDC25A inhibition suppresses the growth and invasion of human hepatocellular carcinoma cells.
Xu X; Yamamoto H; Liu G; Ito Y; Ngan CY; Kondo M; Nagano H; Dono K; Sekimoto M; Monden M
Int J Mol Med; 2008 Feb; 21(2):145-52. PubMed ID: 18204780
[TBL] [Abstract][Full Text] [Related]
11. SRSF10 stabilizes CDC25A by triggering exon 6 skipping to promote hepatocarcinogenesis.
Liu X; Zheng Y; Xiao M; Chen X; Zhu Y; Xu C; Wang F; Liu Z; Cao K
J Exp Clin Cancer Res; 2022 Dec; 41(1):353. PubMed ID: 36539837
[TBL] [Abstract][Full Text] [Related]
12. Meta-analysis of gene expression profiles identifies differential biomarkers for hepatocellular carcinoma and cholangiocarcinoma.
Likhitrattanapisal S; Tipanee J; Janvilisri T
Tumour Biol; 2016 Sep; 37(9):12755-12766. PubMed ID: 27448818
[TBL] [Abstract][Full Text] [Related]
13. Microarray-based identification of genes associated with cancer progression and prognosis in hepatocellular carcinoma.
Yin F; Shu L; Liu X; Li T; Peng T; Nan Y; Li S; Zeng X; Qiu X
J Exp Clin Cancer Res; 2016 Aug; 35(1):127. PubMed ID: 27567667
[TBL] [Abstract][Full Text] [Related]
14. [Expression of epidermal fatty acid-binding protein in cross-species hepatocellular carcinoma].
Shi JL; Cao J; Su JJ; Yang C; Ou C; Wang DP; Li Y
Zhonghua Gan Zang Bing Za Zhi; 2012 Apr; 20(4):270-4. PubMed ID: 22964147
[TBL] [Abstract][Full Text] [Related]
15. Clinical and biological significance of transcription termination factor, RNA polymerase I in human liver hepatocellular carcinoma.
Komatsu H; Iguchi T; Ueda M; Nambara S; Saito T; Hirata H; Sakimura S; Takano Y; Uchi R; Shinden Y; Eguchi H; Masuda T; Sugimachi K; Eguchi H; Doki Y; Mori M; Mimori K
Oncol Rep; 2016 Apr; 35(4):2073-80. PubMed ID: 26821084
[TBL] [Abstract][Full Text] [Related]
16. Identification of the A kinase anchor protein 12 (AKAP12) gene as a candidate tumor suppressor of hepatocellular carcinoma.
Hayashi M; Nomoto S; Kanda M; Okamura Y; Nishikawa Y; Yamada S; Fujii T; Sugimoto H; Takeda S; Kodera Y
J Surg Oncol; 2012 Mar; 105(4):381-6. PubMed ID: 22052684
[TBL] [Abstract][Full Text] [Related]
17. Mybl2 expression is under genetic control and contributes to determine a hepatocellular carcinoma susceptible phenotype.
Frau M; Ladu S; Calvisi DF; Simile MM; Bonelli P; Daino L; Tomasi ML; Seddaiu MA; Feo F; Pascale RM
J Hepatol; 2011 Jul; 55(1):111-9. PubMed ID: 21419759
[TBL] [Abstract][Full Text] [Related]
18. Identification of AKT kinases as unfavorable prognostic factors for hepatocellular carcinoma by a combination of expression profile, interaction network analysis and clinical validation.
Zhang Y; Guo X; Yang M; Yu L; Li Z; Lin N
Mol Biosyst; 2014 Feb; 10(2):215-22. PubMed ID: 24247267
[TBL] [Abstract][Full Text] [Related]
19. Aberrant gene expression profiles in hepatocellular carcinoma detected by microdissection.
Wei YM; Li YY; Zhang YC; Nie YQ
Genet Mol Res; 2013 Nov; 12(4):5527-36. PubMed ID: 24301923
[TBL] [Abstract][Full Text] [Related]
20. Identification of hepatocellular carcinoma-associated hub genes and pathways by integrated microarray analysis.
Liu F; Li H; Chang H; Wang J; Lu J
Tumori; 2015; 101(2):206-14. PubMed ID: 25768320
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]